This review concerns the effects on vision and the eye of medications prescribed at three
phases of treatment for women with early-stage breast cancer (BC):(1) adjuvant cytotoxic …

Newer anticancer drugs have revolutionized cancer treatment in the last decade, but
conventional chemotherapy still occupies a central position in many cancers, with …

Purpose: To review reported retinal side effects from current cancer therapy drugs. Methods:
Retinal toxicities from ophthalmologic or oncologic case reports, case series, and clinical …

Macular edema constitutes a serious pathologic entity of ophthalmology resulting in vision
loss with a remarkable impact on the quality of life of patients. It is the final common pathway …

We present a case of a metastatic breast cancer patient with cystoid macular edema (CME)
occurring during treatment with paclitaxel and bevacizumab. She had a history of …

Bilateral macular oedema is an uncommon side‐effect of paclitaxel administration in
oncological patients. We report the case of a 64‐year‐old man who presented with …

Paclitaxel and nanoparticle albumin-bound paclitaxel are known to cause adverse events of
eye disorders, such as cystoid macular edema. However, at present, the risk factors remain …

Purpose We conducted phase I and tolerability studies to determine the maximum tolerated
dose (MTD) and recommended dose of nab-paclitaxel when administered weekly with solid …

Purpose To evaluate the characteristics of macular retinal and subfoveal choroidal changes
in patients already on taxane-based therapy by the help of spectral domain optical …

Sir, Malignant melanoma is a highly aggressive skin cancer, characterized by a rising
incidence and the early occurrence of metastases. Because of its pronounced resistance to …